Nisa Investment Advisors
MRNS

Nisa Investment Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Nisa Investment Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-76
Closed -$687 – 3000
2024
Q1 		$687 Buy
76
+64
+533% +$622 ﹤0.01% 2443
2023
Q4 		$130 Buy
+12
New +$90 ﹤0.01% 2600
2023
Q3 		– Sell
-32
Closed -$348 – 2859
2023
Q2 		$348 Buy
+32
New +$274 ﹤0.01% 2633
2022
Q2 		– Sell
-16,000
Closed -$150K – 2534
2022
Q1 		$150K Buy
+16,000
New +$159K ﹤0.01% 1489
2020
Q4 		– Sell
-430
Closed -$6K – 2373
2020
Q3 		$6K Hold
430
– – ﹤0.01% 2187
2020
Q2 		$4K Hold
430
– – ﹤0.01% 2028
2020
Q1 		$3K Buy
+430
New +$3.73K ﹤0.01% 2027

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nisa Investment Advisors's MRNS Position: Q2 2024 in Review

Nisa Investment Advisors sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 76 shares — an estimated $687 sold.

Nisa Investment Advisors first reported a position in MRNS in Q1 2020 and held it in 7 quarters. The position peaked at $150K in Q1 2022. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Nisa Investment Advisors reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 76 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $687.
  • Nisa Investment Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q1 2020 and held it in 7 quarters.
  • Nisa Investment Advisors's Marinus Pharmaceuticals, Inc position peaked at $150K in Q1 2022.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.